About the Company
NeurAxis, Inc
BUSINESS DESCRIPTION
NeurAxis is a growth stage company focused on developing neuromodulation therapies to address chronic and debilitating conditions in children. NeurAxis is dedicated to advancing the science with its’ proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. We believe that superior science, evidence-based research, and building on its unparalleled body of clinical evidence is necessary for adoption by the medical...
NeurAxis, Inc News
-
NeurAxis Achieves Major Milestone with AMA Category I CPT® Code Now in Effect, ...
01/08/2026 01:00 PMThe new CPT code reflects the latest efficacious medical care available to patients, facilitating adoption and utilization.The assignment of a Category I CPT® ...
-
Top Stock Reports for Meta, Bank of America & Procter & Gamble...
01/05/2026 09:34 PMMeta Platforms leads today's Zacks Research Daily as analysts highlight strong user growth, heavier AI investment and lingering concerns around monetization....
-
NeurAxis Achieves Medical Coverage Policy Milestone, Expanding Access to Approxi...
12/19/2025 01:00 PMTotal national coverage footprint for PENFS increases to roughly 100 million covered livesCARMEL, Ind., Dec. 19, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“Neu...
-
NeurAxis Secures Veterans Affairs Federal Supply Schedule Contract, Broadening A...
12/01/2025 12:00 PMCARMEL, Ind., Dec. 01, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical technology company commerc...
-
NRXS Stock Declines Post Q3 Earnings Despite Continued Revenue Growth...
11/17/2025 05:17 PMNeurAxis posts its fifth straight quarter of double-digit expansion, but rising costs and margin pressure weigh on third-quarter 2025 results....
-
NeurAxis Announces New Medical Policy Coverage in Michigan, Adding 566,000 Cover...
11/12/2025 01:00 PMCARMEL, Ind., Nov. 12, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical technology company commerc...
-
NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Gro...
11/11/2025 12:00 PMConference call will be held today, Tuesday, November 11 at 9:00 am ETCARMEL, Ind., Nov. 11, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “...
-
NeurAxis to Host Third Quarter 2025 Results and Business Update Call on Tuesday,...
11/04/2025 01:30 PMFinancial results to be released before market open; Conference call to be conducted at 9:00 a.m. Eastern TimeCARMEL, Ind., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Ne...
-
NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pain in Functiona...
10/24/2025 12:00 PMAchieves significant expansion of NeurAxis’ total addressable marketClearance now includes patients aged “8 years and older”Expanded age indication will u...
Disclaimer: